Moderna Inc. stock falls Wednesday, underperforms market

© Terrence Horan


Shares of Moderna Inc. MRNA slid 2.85% to $111.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.15% to 12,870.00 and the Dow Jones Industrial Average DJIA rising 0.24% to 30,409.56. Moderna Inc. closed $67.37 below its 52-week high ($178.50), which the company reached on December 1st.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV rose 0.54% to $105.27, Amgen Inc. AMGN rose 0.13% to $227.17, and AstraZeneca PLC ADR AZN rose 0.56% to $50.18. Trading volume (23.8 M) remained 56,650 below its 50-day average volume of 23.9 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading